Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Prostate Cancer”

745 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 745 results

Large-scale testing (Phase 3)Looking for participantsNCT05956639
What this trial is testing

Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
The First Affiliated Hospital with Nanjing Medical University 100
Large-scale testing (Phase 3)Ended earlyNCT00003645
What this trial is testing

Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 64
Testing effectiveness (Phase 2)UnknownNCT05076851
What this trial is testing

Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy（ADT）for High Risk Prostate Cancer

Who this might be right for
Neoadjuvant Therapy \High Risk Prostate Cancer
Hongqian Guo 2
Testing effectiveness (Phase 2)UnknownNCT00348998
What this trial is testing

Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Virginia Mason Hospital/Medical Center 18
Large-scale testing (Phase 3)Active Not RecruitingNCT03531099
What this trial is testing

Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU (High Intensity Focused Ultrasound) Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Hospices Civils de Lyon 108
Not applicableLooking for participantsNCT00913939
What this trial is testing

High-Dose-Rate Brachytherapy

Who this might be right for
Patients With Prostate Cancer
University Health Network, Toronto 500
Not applicableLooking for participantsNCT06508567
What this trial is testing

Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era

Who this might be right for
Prostate Cancer RecurrentProstate Cancer
University Health Network, Toronto 20
Testing effectiveness (Phase 2)Study completedNCT01667536
What this trial is testing

Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology

Who this might be right for
Prostate Cancer
Molecular Insight Pharmaceuticals, Inc. 105
Large-scale testing (Phase 3)Ended earlyNCT00294437
What this trial is testing

ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases

Who this might be right for
Prostate Cancer
Central European Cooperative Oncology Group 376
Large-scale testing (Phase 3)Ended earlyNCT00005075
What this trial is testing

Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
EDAP Technomed
Testing effectiveness (Phase 2)Active Not RecruitingNCT00859781
What this trial is testing

177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 55
Testing effectiveness (Phase 2)WithdrawnNCT04565496
What this trial is testing

Phase 2 Study of Neoadjuvant PEMbrolizumab Before Radical PROstatectomy in High-risk Prostate Cancer Patients

Who this might be right for
Prostate Cancer
IRCCS San Raffaele
Testing effectiveness (Phase 2)UnknownNCT01890096
What this trial is testing

A Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate Cancer

Who this might be right for
Carcinoma of the Prostate
Sunnybrook Health Sciences Centre 174
Testing effectiveness (Phase 2)Ended earlyNCT04461509
What this trial is testing

High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy

Who this might be right for
Prostatic NeoplasmsGenital Neoplasms, MaleUrogenital Neoplasms+4 more
Alessandro D'Agnolo 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT05498272
What this trial is testing

Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations

Who this might be right for
Prostate CancerBRCA1 MutationBRCA2 Mutation+2 more
Rana McKay, MD 32
Not applicableLooking for participantsNCT07580196
What this trial is testing

Bilateral Versus Unilateral Lymph Node Dissection in High-Risk Prostate Cancer (BALANCE)

Who this might be right for
Prostate Cancer
University of Turin, Italy 820
Early research (Phase 1)WithdrawnNCT06982222
What this trial is testing

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Non-Small Cell Carcinoma+4 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00069888
What this trial is testing

A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy

Who this might be right for
Prostate Cancer
Sanofi 83
Testing effectiveness (Phase 2)Study completedNCT02160353
What this trial is testing

Neo-adjuvant Abiraterone Prostate Study

Who this might be right for
High Risk Localised Prostate Carcinoma
Cancer Trials Ireland 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT06212583
What this trial is testing

High-Risk Metachronous Oligometastatic Prostate Cancer Trial

Who this might be right for
Prostate CancerOligometastatic Disease
University of Maryland, Baltimore 88
Next Page